Correlation between changes in HsTnT levels and LVEF. In the combined treatment groups (CHOP+/-R and CEpOP+/-R ), DLBCL patients with elevated HsTnT levels after 4 cycles of therapy had a more pronounced decline in LVEF than patients with normal HsTnT levels.*P = 0.009